Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Poseida Therapeutics, Inc. (PSTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/14/2023 SC 13D Astellas US LLC reports a 8.7% stake in POSEIDA THERAPEUTICS, INC.
08/11/2023 D Form D - Notice of Exempt Offering of Securities:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Investor Contact:"
08/07/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, ...
Docs: "Securities Purchase Agreement, by and between the Company and Astellas",
"Registration Rights Agreement, by and between the Company and Astellas",
"CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.",
"Investor Contact:",
"Investor Contact:"
06/16/2023 4 Collins Cynthia (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 Schmid John P. (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 Lloyd Marcea Bland (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 BAUM CHARLES M (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 Corning Luke (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/01/2023 8-K Termination of a Material Definitive Agreement, Other Events  Interactive Data
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
05/02/2023 4 Amado Rafael (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 39,300 shares @ $0
Granted 55,200 options to buy @ $2.76, valued at $152.4k
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
03/02/2023 4 Warner Brent (President, Gene Therapy) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 92,772 shares @ $0
Paid exercise price by delivering 26,617 shares @ $5.35, valued at $142.4k
Granted 125,283 options to buy @ $5.35, valued at $670.3k
03/02/2023 4 Mylet Johanna (CFO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 92,772 shares @ $0
Paid exercise price by delivering 4,323 shares @ $5.35, valued at $23.1k
Granted 125,283 options to buy @ $5.35, valued at $670.3k
03/02/2023 4 LEONHARDT HARRY J (GC & Chief Compliance Officer) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 92,772 shares @ $0
Paid exercise price by delivering 4,323 shares @ $5.35, valued at $23.1k
Granted 125,283 options to buy @ $5.35, valued at $670.3k
03/02/2023 4 Gergen Mark J (President and CEO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 269,586 shares @ $0
Granted 364,060 options to buy @ $5.35, valued at $1.9M
02/22/2023 8-K Quarterly results
02/09/2023 SC 13G/A FMR LLC reports a 15% stake in POSEIDA THERAPEUTICS INC
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 8-K Quarterly results
01/17/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/12/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/06/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy